MedTrace Logo

Epidural Clonidine for Lumbosacral Radiculopathy

NCT00588354 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2012-01-11

Study results available
· View outcomes & findings →

Summary

This was a randomized, blinded study of transforaminal epidural injection of clonidine versus a similar injection of corticosteroid for acute lumbosacral radiculopathy. The hypothesis was that clonidine will be as effective as steroid for this condition.

Conditions

  • Lumbar and Other Intervertebral Disc Disorders With Radiculopathy

Interventions

DRUG

Clonidine

200 or 400 micrograms clonidine

DRUG

Triamcinolone hexacetonide

40 or 80 milligrams triamcinolone

DRUG

Lidocaine HCl

1 ml 2% lidocaine (20 mg/mL)

Sponsors & Collaborators

  • National Center for Research Resources (NCRR)

    collaborator NIH

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Marc A Huntoon, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2009-02-28
Completion
2009-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00588354 on ClinicalTrials.gov